Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01582789 · ClinicalTrials.gov registry record · NA
Comparative Study of Two Marketed Spherical Soft Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT01582789: Completed NA study, sponsored by CooperVision.
NCT01582789 is a NA study that has completed, run by CooperVision. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01582789, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain objective and subjective clinical data to compare the performance of two soft contact lenses.
Primary Outcome
Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,
Interventions
- DEVICE senofilcon A
- DEVICE enfilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2012-04-09 |
| Est. Completion | 2012-07-31 |
| Phase | NA |
What the finished NCT01582789 record still lists
NCT01582789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.
NCT01582789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01582789 about?
NCT01582789 is a clinical study titled "Comparative Study of Two Marketed Spherical Soft Contact Lenses". The purpose of this study is to obtain objective and subjective clinical data to compare the performance of two soft contact lenses.
What is the current status of trial NCT01582789?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2012-04-09. Estimated completion is 2012-07-31.
What interventions are being tested in trial NCT01582789?
The interventions under investigation include: senofilcon A (DEVICE), enfilcon A (DEVICE).
Who is sponsoring clinical trial NCT01582789?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01582789's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI